The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2025

Filed:

Feb. 24, 2017
Applicants:

The Binding Site Group Limited, Birmingham, GB;

Mayo Foundation for Medical Education and Research, Rochester, MN (US);

Inventors:

David L. Murray, Rochester, MN (US);

Stephen Harding, Birmingham, GB;

David R. Barnidge, Rochester, MN (US);

Gregg Wallis, Birmingham, GB;

John Mills, Rochester, MN (US);

Jamie Ashby, Birmingham West Midlands, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); C07K 16/00 (2006.01); C07K 16/42 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6854 (2013.01); C07K 16/00 (2013.01); C07K 16/42 (2013.01); G01N 33/6893 (2013.01); C07K 2317/54 (2013.01); G01N 2560/00 (2013.01); G01N 2800/24 (2013.01);
Abstract

An anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof. A method purifying an anti-immunoglobulin specific antibody (or fragment thereof), characterised that the antibody or fragment thereof comprises one or more non-disulphide cross-links between at least one heavy chain or fragment thereof and at least one light chain or fragment thereof of the antibody or fragment thereof. A method of quantifying an amount of a subject analyte, or a fragment of an analyte in a sample from the subject comprising: (i) adding to the sample a predetermined amount of one or more control analytes or fragments thereof, which are distinguishable from the equivalent subject analyte or fragment; (ii) measuring the relative amount of the subject analyte or fragment and the amount of the control analyte or fragment in the sample; and (iii) comparing the relative amount of subject analyte or fragment to the relative amount of control analyte or fragment, to quantify the amount of analyte or fragment in the original subject sample.


Find Patent Forward Citations

Loading…